Donald Engelman

Donald Max Engelman
Alma mater
Awards
Websitemedicine.yale.edu/lab/engelman/
Born1941
EducationReed College, Yale University
AwardsGuggenheim fellow
Scientific career
FieldsCancer drugs and treatments
InstitutionsYale University
ThesisSolubilization and Aggregation Properties of Membrane Components from Mycoplasma laidlawii (1968)
Doctoral studentsMark A. Lemmon[1][2]

Donald Max Engelman (born 1941) is Higgins Professor of Biochemistry at Yale University. He is a member of the National Academy of Sciences (1997), fellow of the American Academy of Arts and Sciences,[3] a fellow of the National Institutes of Health, and has been a Guggenheim fellow.[4] He served as the editor of the Annual Review of Biophysics and Biophysical Chemistry (1984–1993).[5]

He is a director of the Stryker Corporation.[6] He is involved in the creation of new cancer drugs and treatments.[7] For example, Engelman is involved in research to use peptides to aid in destroying tumors.[8]

  1. ^ Lemmon, Mark A.; Flanagan, John M.; Treutlein, Herbert R.; Zhang, Jian; Engelman, Donald M. (1992). "Sequence specificity in the dimerization of transmembrane .alpha.-helixes". Biochemistry. 31 (51): 12719–12725. doi:10.1021/bi00166a002. PMID 1463743.
  2. ^ Lemmon, Mark Andrew (1993). Specific interactions between transmembrane alpha-helices: Their role in the oligomerization of integral membrane proteins (PhD thesis). Yale University. ProQuest 304065037. (subscription required)
  3. ^ "REED COLLEGE AMERICAN ACADEMY OF ARTS AND SCIENCES AWARDS".
  4. ^ "All Fellows - John Simon Guggenheim Memorial Foundation". Gf.org. Archived from the original on 2011-06-28. Retrieved 2011-07-06.
  5. ^ "Engelman and de la Huerga join the board of trustees". Reed Magazine. August 2000. Retrieved 17 December 2020.
  6. ^ "Donald M. Engelman Profile - Forbes.com". People.forbes.com. Retrieved 2011-07-06.[dead link]
  7. ^ redOrbit (27 October 2009). "URI Research Couple's Method Targets Cancerous Tumors - Redorbit". Redorbit.
  8. ^ "Home".

© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search